Go to the list of all blogs
Sarah Patel's Avatar
published in Blogs
Dec 30, 2022

TG Therapeutics (TGTX, $10.40) gets FDA nod on RMS-treating antibody

The U.S. Food and Drug Administration (FDA) approved TG Therapeutics Inc's Briumvi – a monoclonal antibody for treating patients with relapsing forms of multiple sclerosis (RMS).  Briumvi is the first and only anti-CD20 monoclonal antibody approved for RMS that can be administered in a one-hour infusion following the first dose.

The approval by the FDA may help offset the headwind to the company's finances from the withdrawal of its lymphatic cancer drug earlier this year. The approval was based on a late-stage study that suggested that the drug was effective in mitigating the annualized relapse rates in patients. It, however, comes with a caution of infusion reactions from the drug.

TG expects to launch Briumvi commercially in the U.S. in the first quarter of 2023.

Related Ticker: TGTX

TGTX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for TGTX moved above the 200-day moving average on February 20, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 28, 2024. You may want to consider a long position or call options on TGTX as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TGTX just turned positive on February 28, 2024. Looking at past instances where TGTX's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

TGTX moved above its 50-day moving average on February 28, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where TGTX advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The 10-day moving average for TGTX crossed bearishly below the 50-day moving average on February 05, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TGTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TGTX broke above its upper Bollinger Band on February 28, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TGTX entered a downward trend on February 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TGTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TGTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.863) is normal, around the industry mean (28.923). P/E Ratio (198.667) is within average values for comparable stocks, (125.960). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.190). Dividend Yield (0.000) settles around the average of (0.031) among similar stocks. P/S Ratio (11.364) is also within normal values, averaging (439.695).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.61B. The market cap for tickers in the group ranges from 402 to 552.32B. NVO holds the highest valuation in this group at 552.32B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 4%. For the same Industry, the average monthly price growth was 19%, and the average quarterly price growth was 54%. BMNDF experienced the highest price growth at 241%, while NERV experienced the biggest fall at -62%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 34%. For the same stocks of the Industry, the average monthly volume growth was 104% and the average quarterly volume growth was 63%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 86
Price Growth Rating: 52
SMR Rating: 94
Profit Risk Rating: 93
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
TGTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
226
Web
https://www.tgtherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMUX23.900.14
+0.57%
Carillon Scout Mid Cap R-6
AFCWX16.340.03
+0.18%
American Century Focused Intl Gr R
RICEX54.13-0.01
-0.02%
American Funds Invmt Co of Amer R4
TSTRX17.12-0.02
-0.12%
Transamerica Stock Index R
NEFSX39.26-0.22
-0.56%
Natixis US Equity Opportunities A

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with ARRY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
-0.45%
ARRY - TGTX
36%
Loosely correlated
-5.73%
AXON - TGTX
36%
Loosely correlated
+1.76%
AMRN - TGTX
34%
Loosely correlated
-12.84%
BEAM - TGTX
33%
Loosely correlated
-4.02%
NTLA - TGTX
33%
Loosely correlated
-0.83%
More
Ad is loading...
The Thermals group has shown remarkable resilience and growth, with a remarkable performance increase of +4.57% over the last month. Comprising tickers such as DAN, INTT, BRKR, WAT, and PNR, this group is at the forefront of thermal analysis and related technologies. In this article, we delve into the performance of these stocks, explore their market capitalization, price trends, and highlight specific insights for three key tickers: DAN, INTT, and PNR.
This week, the market has shown a promising turnaround and is likely to continue its growth. Industrial Machinery stocks have performed well, with some seeing gains of 3-5% over the past week. You can check out signals for these companies' stocks in our robot: Swing-Trader-1-5K-per-position-Medium-Volatility-Stocks-for-Active-Trading-TA-FA.
The pharmaceuticals generic industry is a significant player in the global drug market. Generic drugs, which contain the same chemical substance as their patented counterparts, are sold at more affordable prices once the patents for the original drugs expire. This affordability has led to the vast popularity of generic drugs.
#artificial_intelligence
One notable example is the "Day Trader: Medium Volatility Stocks for Active Trading (TA&FA)" bot, which has demonstrated its prowess as more than just a trading tool – it's a bot factory generating remarkable gains. Over the previous week, this AI trading bot managed to achieve a remarkable +8.37% gain by actively trading NVDA, a clear testament to the potential of combining technical and fundamental analysis with automated trading strategies.
The Tobacco industry has demonstrated a remarkable upswing in its performance over the past week, with a significant increase of +4.31%. This positive momentum is reflected across a group of prominent tickers within the industry, including XXII, GNLN, RLX, KAVL, and HPCO.
Dive into the fascinating world of nuclear energy as we uncover the remarkable gains achieved by top performers in the industry. Stocks like $HII, $BWXT, $PESI, $LTBR, and $WVE have surged by an impressive +14.14%. Discover the driving forces behind these remarkable market movements and the potential opportunities they unveil. Don't miss out on the insights that could reshape your investment strategy!
#latest#popular#artificial_intelligence#trading#technical_analysis#asset_allocation
Thermo Fisher Scientific ($TMO) emerges as a beacon of hope for investors, registering a remarkable 5.38% jump this week. Dive in to discover what's fueling TMO's impressive ascent in the Medical Specialties sector. 🚀📈
#latest#popular#artificial_intelligence#trading#neutral_bluish
Automation has seamlessly integrated into various facets of our daily lives. From simplifying money transfers to revolutionizing industrial operations and enhancing security services, the scope of automation is vast and ever-expanding.
#artificial_intelligence
One prominent player in this arena is the "Swing trader: Long-Short Equity Strategy (TA&FA)" bot, which recently demonstrated its prowess by achieving an impressive +5.12% gain while trading MRNA over the past week. This article delves into the latest earnings report, market trends, and the role of AI-driven trading in navigating these waters.
The Other Transportation industry has witnessed a remarkable surge of +11.1% in its performance over the past week, catching the attention of investors and analysts alike. This article delves into the exciting developments within this industry, with a specific focus on two key tickers: ASLE and UP.
This week, the market is showing significant growth, especially in the semiconductor sector, where company stocks are rising by 5-7%. Our robots have actively participated in this and achieved some good results. If you want to receive instant signals for successful trades, subscribe to one of our robots at the following link:Swing-Trader-1-5K-per-position-Medium-Volatility-Stocks-for-Active-Trading-TA-FA Let's earn together on the market's upward trend!
These AI trading robots, accessible at "Swing trader: Downtrend Protection (TA)," have proven their mettle by delivering a remarkable +4.72% gain while trading TSLA over the course of the previous week. In this article, we delve into the recent performance of TSLA, analyzing its earnings results, market capitalization, price trends, and trading volume to provide valuable insights for investors.
Discover how the shale oil sector is making waves, with impressive gains of +5.24%. Dive into the market movements of key players like $XOM, $BHP, $EOG, $PXD, and $HES, as we uncover the dynamics driving this surge in the energy industry. Explore the latest trends, price shifts, and indicators that could shape the future of shale oil investments.
In a week dominated by bullish sentiment, Alphabet (GOOG) emerges triumphant, registering an impressive +5.28% rise. Dive into the factors propelling this tech titan's stock performance and what it might signal for the future." 🌐💹🚀
#popular#latest#artificial_intelligence#neutral_bluish#trading#technical_analysis#asset_allocation
The Homebuilding industry has experienced a significant increase of +8.85% in its performance over the past week. This surge in performance has not only captured the attention of investors but has also sparked optimism for the future of the sector. In this article, we'll delve into the theme of the Homebuilding industry, examine the group of tickers within it, and highlight some notable developments.
In the ever-evolving world of trading, AI trading robots are becoming increasingly popular due to their ability to analyze vast amounts of data and make quick, data-driven decisions. One such AI trading robot, known as "Swing trader: Deep Trend Analysis v.2 (TA)," recently made headlines with an impressive +4.35% gain while trading FUBO over the course of the previous week. In this article, we'll delve into the technical analysis of FUBO's recent performance, earnings results, and broader market trends.
One such industry that has recently caught the attention of financial analysts is the Office Equipment/Supplies Industry. In the past week, this industry has displayed remarkable performance, with a notable increase of +5.46%. Let's delve into the theme and the group of tickers within it to better understand this surge.
Discover the Power of Tech Peripherals: Join us as we delve into the recent +7.48% gain by top tickers $HPQ, $SMCI, $ALOT, $INVE, $SSYS. Uncover market insights and potential opportunities in the computer peripherals sector. 📈💼 #TechPeripherals #StockMarket"
#trading#latest#popular#artificial_intelligence#neutral_bluish#asset_allocation
Lululemon Athletica's recent surge is making headlines, with a notable +11.00% uptick. Dive into the numbers, trends, and predictions surrounding LULU's performance, and discover where the stock might be headed next. 📈👕🚀
#latest#popular#artificial_intelligence#neutral_bluish#trading#asset_allocation
Join the ranks of smart traders who have already experienced the benefits of Tickeron's robust algorithm. Don't let market uncertainty hold you back any longer – take control of your financial future with a strategy that can withstand the test of time.